$0.540000
-0.01-1.82%
At Close: -
$0.545000
0.00500.93%
After Hours: 7:59 PM EDT
15 minutes delayed
Comments
Loading...
Citius Pharma (NASDAQ:CTXR) Stock, Earnings Estimates, EPS, And Revenue
Citius Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS
$-0.060
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Citius Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Citius Pharma (CTXR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-12 | $-0.06 | $-0.06 | 0.00 % |
| Mar 2024 | 2024-05-14 | $-0.05 | $-0.05 | 0.00 % |
| Mar 2023 | 2023-05-12 | $-0.07 | $-0.03 | -133.3 % |
| Sep 2022 | 2022-12-22 | $-0.05 | $-0.04 | -25.0 % |
Citius Pharma (CTXR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Citius Pharma (NASDAQ:CTXR) reporting earnings?
Citius Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Citius Pharma (NASDAQ:CTXR)?
Citius Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 12, 2024 for Q3 and the Actual EPS was $-0.06, which hit the estimate of $-0.06.
What were Citius Pharma’s (NASDAQ:CTXR) revenues?
Citius Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.